Register now!

Policies on in silico medicine are in their infancy. The Avicenna Alliance views early cooperation and harmonization of policies across borders to be of key importance to enabling the in silico market.

Too many policies have been developed across continents without any consultation with 3rd countries, the result being vastly differing Regulatory systems that pose obstacles for market development and unnecessary costs for all.

In order to avoid the need for retrospective harmonization, the Avicenna Alliance Working EU/US/Asia-Pacific Working Group will engage with colleagues and organisations in our field to ensure we achieve harmonization from the very beginning.

Avicenna Alliance news

Avicenna Alliance – Review 2016

A look back at the year 2016 reveals that it has been a very successful first year for the Avicenna Alliance.

find out more ›

Professional Engineering magazine interviews Avicenna Alliance Secretary General

For its December 2016 issue, Professional Engineering, the magazine for the 110,000 members of the Institution of...

find out more ›

Maltese Presidency of the Council of the European Union published its official programme – relevant aspects for Avicenna Alliance

As part of the rotating Presidency of the Council of the European...

find out more ›

Show all activites